Gsk (GSK) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Powered by 
Analysis
Gsk (GSK) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 618.86 Bn | 602.88 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 361.40 Bn | 361.40 Bn | - |
| 3 | General Electric | 329.38 Bn | 320.03 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.73 Bn | 248.44 Bn | 12.86 Bn |
| 5 | Citigroup | 228.07 Bn | -2,074.24 Bn | 24.75 Bn |
| 6 | Bhp | 216.09 Bn | 197.55 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 197.36 Bn | 195.32 Bn | - |
| 9 | Unilever | 139.15 Bn | 132.12 Bn | - |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -75.08% |
| Mar 31, 2026 | -42.60% |
| Dec 31, 2025 | 50.19% |
| Sep 30, 2025 | 41.10% |
| Jun 30, 2025 | -5.89% |
| Mar 31, 2025 | -28.18% |
| Dec 31, 2024 | 3,879.34% |
| Sep 30, 2024 | -105.09% |
| Jun 30, 2024 | 11.58% |
| Mar 31, 2024 | -65.67% |
| Dec 31, 2023 | 108.42% |
| Sep 30, 2023 | -8.75% |
| Jun 30, 2023 | 12.21% |
| Mar 31, 2023 | -41.51% |
| Dec 31, 2022 | -75.72% |
| Sep 30, 2022 | 1,108.47% |
| Jun 30, 2022 | -56.36% |
| Mar 31, 2022 | -27.32% |
| Dec 31, 2021 | 106.62% |
| Sep 30, 2021 | -17.42% |